Global Personalized Cell Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Personalized Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Hematopoietic Stem Cell
  • 1.3.3 Skeletal Muscle Stem Cell
  • 1.3.4 Mesenchymal Stem Cells
  • 1.3.5 Lymphocytes
  • 1.3.6 Others
• 1.4 Market by Application
  • 1.4.1 Global Personalized Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.4.2 Cardiovascular Diseases
  • 1.4.3 Neurological Disorders
  • 1.4.4 Inflammatory Diseases
  • 1.4.5 Diabetes
  • 1.4.6 Cancer
  • 1.4.7 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Cell Therapy Market Perspective (2015-2026)
• 2.2 Personalized Cell Therapy Growth Trends by Regions
  • 2.2.1 Personalized Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Personalized Cell Therapy Industry Dynamic
  • 2.3.1 Personalized Cell Therapy Market Trends
  • 2.3.2 Personalized Cell Therapy Market Drivers
  • 2.3.3 Personalized Cell Therapy Market Challenges
  • 2.3.4 Personalized Cell Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Cell Therapy Players by Market Size
  • 3.1.1 Global Top Personalized Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Cell Therapy Revenue Market Share by Players (2015-2020)
• 3.2 Global Personalized Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Personalized Cell Therapy Revenue
• 3.4 Global Personalized Cell Therapy Market Concentration Ratio
  • 3.4.1 Global Personalized Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cell Therapy Revenue in 2019
• 3.5 Key Players Personalized Cell Therapy Area Served
• 3.6 Key Players Personalized Cell Therapy Product Solution and Service
• 3.7 Date of Enter into Personalized Cell Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cell Therapy Breakdown Data by Type

• 4.1 Global Personalized Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Personalized Cell Therapy Breakdown Data by Application

• 5.1 Global Personalized Cell Therapy Historic Market Size by Application (2015-2020)
• 5.2 Global Personalized Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Cell Therapy Market Size (2015-2026)
• 6.2 North America Personalized Cell Therapy Market Size by Type (2015-2020)
• 6.3 North America Personalized Cell Therapy Market Size by Application (2015-2020)
• 6.4 North America Personalized Cell Therapy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Personalized Cell Therapy Market Size (2015-2026)
• 7.2 Europe Personalized Cell Therapy Market Size by Type (2015-2020)
• 7.3 Europe Personalized Cell Therapy Market Size by Application (2015-2020)
• 7.4 Europe Personalized Cell Therapy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Personalized Cell Therapy Market Size (2015-2026)
• 8.2 Asia-Pacific Personalized Cell Therapy Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Personalized Cell Therapy Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Personalized Cell Therapy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Personalized Cell Therapy Market Size (2015-2026)
• 9.2 Latin America Personalized Cell Therapy Market Size by Type (2015-2020)
• 9.3 Latin America Personalized Cell Therapy Market Size by Application (2015-2020)
• 9.4 Latin America Personalized Cell Therapy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Personalized Cell Therapy Market Size (2015-2026)
• 10.2 Middle East & Africa Personalized Cell Therapy Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Personalized Cell Therapy Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Personalized Cell Therapy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Novartis AG
  • 11.1.1 Novartis AG Company Details
  • 11.1.2 Novartis AG Business Overview
  • 11.1.3 Novartis AG Personalized Cell Therapy Introduction
  • 11.1.4 Novartis AG Revenue in Personalized Cell Therapy Business (2015-2020))
  • 11.1.5 Novartis AG Recent Development
• 11.2 Vericel Corporation
  • 11.2.1 Vericel Corporation Company Details
  • 11.2.2 Vericel Corporation Business Overview
  • 11.2.3 Vericel Corporation Personalized Cell Therapy Introduction
  • 11.2.4 Vericel Corporation Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.2.5 Vericel Corporation Recent Development
• 11.3 Bellicum Pharmaceuticals
  • 11.3.1 Bellicum Pharmaceuticals Company Details
  • 11.3.2 Bellicum Pharmaceuticals Business Overview
  • 11.3.3 Bellicum Pharmaceuticals Personalized Cell Therapy Introduction
  • 11.3.4 Bellicum Pharmaceuticals Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.3.5 Bellicum Pharmaceuticals Recent Development
• 11.4 MolMed SpA
  • 11.4.1 MolMed SpA Company Details
  • 11.4.2 MolMed SpA Business Overview
  • 11.4.3 MolMed SpA Personalized Cell Therapy Introduction
  • 11.4.4 MolMed SpA Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.4.5 MolMed SpA Recent Development
• 11.5 Cytori Therapeutics Inc
  • 11.5.1 Cytori Therapeutics Inc Company Details
  • 11.5.2 Cytori Therapeutics Inc Business Overview
  • 11.5.3 Cytori Therapeutics Inc Personalized Cell Therapy Introduction
  • 11.5.4 Cytori Therapeutics Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.5.5 Cytori Therapeutics Inc Recent Development
• 11.6 Gilead Sciences, Inc
  • 11.6.1 Gilead Sciences, Inc Company Details
  • 11.6.2 Gilead Sciences, Inc Business Overview
  • 11.6.3 Gilead Sciences, Inc Personalized Cell Therapy Introduction
  • 11.6.4 Gilead Sciences, Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.6.5 Gilead Sciences, Inc Recent Development
• 11.7 Celgene Corporation
  • 11.7.1 Celgene Corporation Company Details
  • 11.7.2 Celgene Corporation Business Overview
  • 11.7.3 Celgene Corporation Personalized Cell Therapy Introduction
  • 11.7.4 Celgene Corporation Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.7.5 Celgene Corporation Recent Development
• 11.8 Bluebird Bio
  • 11.8.1 Bluebird Bio Company Details
  • 11.8.2 Bluebird Bio Business Overview
  • 11.8.3 Bluebird Bio Personalized Cell Therapy Introduction
  • 11.8.4 Bluebird Bio Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.8.5 Bluebird Bio Recent Development
• 11.9 Aurora Biopharma Inc
  • 11.9.1 Aurora Biopharma Inc Company Details
  • 11.9.2 Aurora Biopharma Inc Business Overview
  • 11.9.3 Aurora Biopharma Inc Personalized Cell Therapy Introduction
  • 11.9.4 Aurora Biopharma Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.9.5 Aurora Biopharma Inc Recent Development
• 11.10 Saneron CCEL Therapeutics，Inc
  • 11.10.1 Saneron CCEL Therapeutics，Inc Company Details
  • 11.10.2 Saneron CCEL Therapeutics，Inc Business Overview
  • 11.10.3 Saneron CCEL Therapeutics，Inc Personalized Cell Therapy Introduction
  • 11.10.4 Saneron CCEL Therapeutics，Inc Revenue in Personalized Cell Therapy Business (2015-2020)
  • 11.10.5 Saneron CCEL Therapeutics，Inc Recent Development
• 11.11 Kuur Therapeutics
  • 10.11.1 Kuur Therapeutics Company Details
  • 10.11.2 Kuur Therapeutics Business Overview
  • 10.11.3 Kuur Therapeutics Personalized Cell Therapy Introduction
  • 10.11.4 Kuur Therapeutics Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.11.5 Kuur Therapeutics Recent Development
• 11.12 MediGene AG
  • 10.12.1 MediGene AG Company Details
  • 10.12.2 MediGene AG Business Overview
  • 10.12.3 MediGene AG Personalized Cell Therapy Introduction
  • 10.12.4 MediGene AG Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.12.5 MediGene AG Recent Development
• 11.13 Sangamo Therapeutics
  • 10.13.1 Sangamo Therapeutics Company Details
  • 10.13.2 Sangamo Therapeutics Business Overview
  • 10.13.3 Sangamo Therapeutics Personalized Cell Therapy Introduction
  • 10.13.4 Sangamo Therapeutics Revenue in Personalized Cell Therapy Business (2015-2020)
  • 10.13.5 Sangamo Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer